AZALEP a randomized controlled trial of azathioprine to treat leprosy nerve damage and Type 1 reactions in India: Main findings.

• Autori principali: Diana N J Lockwood (Autore), Joydeepa Darlong (Autore), Pitchaimani Govindharaj (Autore), Royce Kurian (Autore), Pamidipani Sundarrao (Autore), Annamma S John (Autore)
• Natura: Libro
• Pubblicazione: Public Library of Science (PLoS), 2017-03-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

BACKGROUND:Leprosy Type 1 reactions are difficult to treat and only 70% of patients respond to steroid treatment. Azathioprine has been used as an immune-suppressant and we tested its efficacy in treating leprosy T1R. METHODOLOGY:Randomised controlled trial adding azathioprine to steroid treatment f...